Repeat Administration of Polyethylenimine (PEI) Aerosols of Plasmid DNA to the Murine Lung is Associated with a Loss of Gene Transfer Efficiency. (2005)

Davies, L. A., Hyde, S. C. & Gill, D. R.

Molecular Therapy, 11, S137

Download   Back

Gene therapy for many chronic diseases will require long-term gene expression and/or repeated administration. We are investigating gene transfer to the terminally differentiated epithelial cells of the airways, the target for the treatment of cystic fibrosis lung disease. Unlike many viral vectors where repeat administration may be severely compromised by neutralizing antibodies, non-viral vectors such as cationic polymers and cationic lipids are not associated with significant immune responses in the lung and may provide a more appropriate alternative for long term gene therapy. We have utilised aerosol delivery of PEI/DNA complexes to the lungs of mice as a model to investigate gene expression following repeat administration of this non-viral gene transfer agent in vivo. Female BALB/c mice housed in a whole body aerosol exposure chamber were exposed repeatedly to aerosols containing 25kDa branched PEI (Sigma, Poole, UK) complexed to plasmid DNA expressing the firefly luciferase gene under control of the cytomegalovirus immediate/early promoter. A total of 4 aerosol doses were delivered at intervals of 7 days. Following each aerosol exposure, groups of mice were sacrificed after 1 day and 7 days and luciferase expression was assayed in whole lung homogenates. Following a single exposure to PEI aerosol, robust luciferase expression at 68.0 ± 10.3 RLU/mg (mean ± SEM) protein was detected in the lungs of treated mice at 24 hrs after exposure. The observed expression was transient and had fallen to 4.7 ± 1.2 RLU/mg by the time of the second aerosol exposure at 7 days. Following a second aerosol, high levels of luciferase expression were again detected in the lungs of treated mice but maximal expression reached only 49.3 ± 3.8 RLU/mg at 24 hrs (p=0.027 compared to initial dose using ANOVA/PLSD analysis). Further reductions in lung luciferase levels were observed following the third and fourth aerosol exposures where luciferase levels reached only 15.8 ± 1.9 RLU/mg (p<0.0001) and 13.3 ± 2.1 RLU/mg (p<0.0001) respectively. NaÔve mice exposed contemporaneously showed no equivalent fall in luciferase expression. Subsequent experiments to investigate the mechanism behind the observed fall in luciferase expression upon repeat administration of PEI/DNA showed that the effect was independent of the transgene used. In addition, prior exposure to aerosols containing PEI alone was sufficient to mediate the loss of transfection efficiency. These results demonstrate that repeat administration of 25kDa PEI/DNA aerosols to the lung is associated with a significant loss of transfection efficiency upon re-administration at intervals of 7 days. Experiments are currently underway to determine if the observed results represent a refractory period for effective aerosol re-administration and if longer dosing intervals may permit restoration of initial gene expression levels in this model system.

Home
News
Introductory Videos
Medical Futures Innovation Award 2011
Twitter Feed
About Us
Contact Us
Careers
Resources
Lab Events
Environemental Policy
About this Site

Google Site Search

Site Feedback Form

All Site Images

 

UK CFGTC

How the Consortium works/FAQs

Consortium Website

Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial

Milestones

GL67A/pGM169

The Run-in Study

Single Dose Clinical Trial

Multi Dose Clinical Trial

 

Our Research

Non-viral Vector Development

Aerosol Mediated Gene Delivery

Viral Vector Development

Taqman Core Facility

Cystic Fibrosis

History of CF

Discovery of the CFTR Gene

CFTR Protein Structure

CFTR Function

CF Links

 

Gene Therapy

Introduction to Gene Therapy

Other CF Gene Therapy Groups

Why use Gene Therapy for CF

Target Cells for CF Gene Therapy

Barriers for CF Gene Therapy

Clinical Trials

Gene Therapy Successes

Gene Therapy Links

 

 

Publications

Papers in Journals

Conference Posters & Presentations

Book Chapters

D.Phil Theses

Lectures

 

Gene Therapy Seminars

Schedule

Directions & Venue